試題詳解

73. 依據 BCLC 2022 update，BCLC B 下列何者錯誤？
(1) The treatment options include LT, TACE and systemic therapy.
(2) AFP higher than 1,000 ng/dl is currently applied as an exclusion criterion of
LT in BCLC B HCC.
(3) BCLC B patients with an AFP ＞1,000 ng/ml who experienced biochemical
response (at least a decrease to less than 500 ng/ml) to locoregional therapies have post-LT outcomes inferior to those reported for patients within Milan criteria.
(4) For patients to be candidates for TACE, increased bilirubin beyond 2 mg or
slight fluid retention requiring diuretic treatment are suboptimal survival after
TACE.
(A) (3)
(B) (2)
(C) (2)＋(3)
(D) (3)＋(4)

(E) (1)＋(3)